Citations

Mayo Clinic

Showing 10 of 108522 citations.

Commentary on “Artificial Intelligence in Dermatology: A Systematic Review of Its Applications in Melanoma and Keratinocyte Carcinoma Diagnosis” and “Artificial Intelligence for Mohs and Dermatologic Surgery: A Systematic Review and Meta-Analysis”
Vidal, Nahid Y.

Dermatologic Surgery | August 19, 2024 | Volume: 50 | Issue: 9 | Pages: 807-808

10.1097/dss.0000000000004380 | PMID 39159392 Get It

Prospective Cohort Study Examining the Ability of Performance‐Based and Self‐Reported Frailty Measures to Predict 30‐Day Rehospitalizations After Kidney Transplantation
Lorenz, Elizabeth C. , Smith, Byron H. , Mour, Girish , Wadei, Hani M. , Kennedy, Cassie C. , Schinstock, Carrie A. , Kremers, Walter K. , Cheville, Andrea , LeBrasseur, Nathan K. , Rule, Andrew D. , Cheville, Andrea L , Rule, Andrew D , Smith, Byron , Schinstock, Carrie , Kennedy, Cassie C , LeBrasseur, Nathan K , Wadei, Hani M , Kremers, Walter K , Mour, Girish K

Clinical Transplantation | August 19, 2024 | Volume: 38 | Issue: 8 | Pages: No page available

10.1111/ctr.15433 | PMID 39158949 Get It

ABSTRACTPerformance‐based measures of frailty are associated with healthcare utilization after kidney transplantation (KT) but require in‐person assessment. A promising alternative is self‐reported frailty. The goal of this study was to examine the ability of performance‐based and self‐reported frailty measures to predict 30‐day rehospitalizations after KT. We conducted a prospective, observational cohort study involving 272 adults undergoing KT at Mayo Clinic in Minnesota, Florida, or Arizona. We simultaneously measured frailty before KT using the physical frailty phenotype (PFP), the short physical performance battery (SPPB), and self‐report (the Patient‐Reported Outcomes Measurement Information System [PROMIS] 4‐item physical function short form v2.0). Both the PFP and self‐reported frailty were independently associated with more than a 2‐fold greater odds of 30‐day rehospitalizations, while the SPPB was not. To our knowledge, this is the first study to assess the prognostic value of all three of the above frailty measures in patients undergoing KT. The PFP is more prognostic than the SPPB when assessing the risk of 30‐day rehospitalizations; self‐reported frailty can complement the PFP but not replace it. However, the 4‐item survey assessing self‐reported frailty represents a simple way to identify patients undergoing KT surgery who would benefit from interventions to lower the risk of rehospitalizations.
Tranexamic Acid in Patients Undergoing Liver Resection
Karanicolas, Paul J. , Lin, Yulia , McCluskey, Stuart A. , Tarshis, Jordan , Dixon, Elijah , Porter, Geoff , Chaudhury, Prosanto , Nanji, Sulaiman , Ruo, Leyo , Tsang, Melanie E. , Skaro, Anton , Eeson, Gareth, Moulton, Carol-Anne, Ball, Chad G. , Hallet, Julie, Coburn, Natalie, Jayaraman, Shiva, Law, Calvin, Tandan, Ved, Nagorney, David, Quan, Douglas , Smoot, Rory L. , Gallinger, Steven, Metrakos, Peter , Reichman, Trevor , Jalink, Diederick, Bennett, Sean, Sutherland, Francis, Solano, Edward, Molinari, Michele , Tang, Ephraim , Bathe, Oliver F. , Barkun, Jeffrey , Kendrick, Michael L., Truty, Mark J. , Roke, Rachel , Xu, Grace , Lafrenière‐Roula, Myriam , Team, HPB CONCEPT, Truty, Mark, Smoot, Rory L , Thorpe, Kevin E. , Wei, Alice C. , Cleary, Sean P. , Serrano, Pablo E , Sapisochín, Gonzalo , Warner, Susanne G. , Kendrick, Michael L. , Guyatt, Gordon , Team, HPB CONCEPT

JAMA | August 19, 2024 | Volume: 332 | Issue: 13 | Pages: 1080

10.1001/jama.2024.11783 | PMID 39158894 Get It

ImportanceTranexamic acid reduces bleeding and blood transfusion in many types of surgery, but its effect in patients undergoing liver resection for a cancer-related indication remains unclear.ObjectiveTo determine whether tranexamic acid reduces red blood cell transfusion within 7 days of liver resection.Design, Setting, and ParticipantsMulticenter randomized clinical trial of tranexamic acid vs placebo conducted from December 1, 2014, to November 8, 2022, at 10 hepatopancreaticobiliary sites in Canada and 1 site in the United States, with 90-day follow-up. Participants, clinicians, and data collectors were blinded to allocation. A volunteer sample of 1384 patients undergoing liver resection for a cancer-related indication met eligibility criteria and consented to randomization.InterventionsTranexamic acid (1-g bolus followed by 1-g infusion over 8 hours; n = 619) or matching placebo (n = 626) beginning at induction of anesthesia.Main Outcomes and MeasuresThe primary outcome was receipt of red blood cell transfusion within 7 days of surgery.ResultsThe primary analysis included 1245 participants (mean age, 63.2 years; 39.8% female; 56.1% with a diagnosis of colorectal liver metastases). Perioperative characteristics were similar between groups. Red blood cell transfusion occurred in 16.3% of participants (n = 101) in the tranexamic acid group and 14.5% (n = 91) in the placebo group (odds ratio, 1.15 [95% CI, 0.84-1.56]; P = .38; absolute difference, 2% [95% CI, −2% to 6%]). Measured intraoperative blood loss (tranexamic acid, 817.3 mL; placebo, 836.7 mL; P = .75) and total estimated blood loss over 7 days (tranexamic acid, 1504.0 mL; placebo, 1551.2 mL; P = .38) were similar between groups. Participants receiving tranexamic acid experienced significantly more complications compared with placebo (odds ratio, 1.28 [95% CI, 1.02-1.60]; P = .03), with no significant difference in venous thromboembolism (odds ratio, 1.68 [95% CI, 0.95-3.07]; P = .08).Conclusions and RelevanceAmong patients undergoing liver resection for a cancer-related indication, tranexamic acid did not reduce bleeding or blood transfusion but increased perioperative complications.Trial RegistrationClinicalTrials.gov Identifier: NCT02261415
Grounded in Reality: Integrating Community Values and Priorities of End Users in Human Gene Editing
Riggan, Kirsten A. , Feys, Roel , Kokayi, Assata , Meagher, Karen M. , Michie, Marsha , Musunuru, Kiran , Ormond, Kelly E. , Schelhaas, Andrea J. , Yap, Jane Q. , Isasi, Rosario , Allyse, Megan , Allyse, Megan A , Meagher, Karen M , Riggan, Kirsten A , Yap, Jane Q

The American Journal of Bioethics | August 19, 2024 | Volume: 24 | Issue: 8 | Pages: 43-45

10.1080/15265161.2024.2361880 | PMID 39158441 Get It

Implementation and impact of an electronic patient reported outcomes system in a phase II multi-site adaptive platform clinical trial for early-stage breast cancer
Northrop, Anna, Christofferson, Anika, Umashankar, Saumya , Melisko, Michelle , Castillo, Paolo, Brown, Thelma, Heditsian, Diane , Brain, Susie, Simmons, Carol A., Ruddy, Kathryn J. , Mainor, Candace , Afghahi, Anosheh , Tevis, Sarah , Esserman, Laura J. , Hieken, Tina, Blaes, Anne H , Esserman, Laura J , Brown, Thelma, Simmons, Carol, Hieken, Tina J. , Blaes, Anne , Kang, Irene , Asare, Adam L. , Hershman, Dawn L. , Basu, Amrita B

Journal of the American Medical Informatics Association | August 19, 2024 | Volume: 32 | Issue: 1 | Pages: 172-180

10.1093/jamia/ocae190 | PMID 39158353 Get It

Abstract Objectives We describe the development and implementation of a system for monitoring patient-reported adverse events and quality of life using electronic Patient Reported Outcome (ePRO) instruments in the I-SPY2 Trial, a phase II clinical trial for locally advanced breast cancer. We describe the administration of technological, workflow, and behavior change interventions and their associated impact on questionnaire completion. Materials and Methods Using the OpenClinica electronic data capture system, we developed rules-based logic to build automated ePRO surveys, customized to the I-SPY2 treatment schedule. We piloted ePROs at the University of California, San Francisco (UCSF) to optimize workflow in the context of trial treatment scenarios and staggered rollout of the ePRO system to 26 sites to ensure effective implementation of the technology. Results Increasing ePRO completion requires workflow solutions and research staff engagement. Over two years, we increased baseline survey completion from 25% to 80%. The majority of patients completed between 30% and 75% of the questionnaires they received, with no statistically significant variation in survey completion by age, race or ethnicity. Patients who completed the screening timepoint questionnaire were significantly more likely to complete more of the surveys they received at later timepoints (mean completion of 74.1% vs 35.5%, P < .0001). Baseline PROMIS social functioning and grade 2 or more PRO-CTCAE interference of Abdominal Pain, Decreased Appetite, Dizziness and Shortness of Breath was associated with lower survey completion rates. Discussion and Conclusion By implementing ePROs, we have the potential to increase efficiency and accuracy of patient-reported clinical trial data collection, while improving quality of care, patient safety, and health outcomes. Our method is accessible across demographics and facilitates an ease of data collection and sharing across nationwide sites. We identify predictors of decreased completion that can optimize resource allocation by better targeting efforts such as in-person outreach, staff engagement, a robust technical workflow, and increased monitoring to improve overall completion rates. Trial Registration https://clinicaltrials.gov/study/NCT01042379.
Cognitive, motor, and autonomic function among individuals with serotonergic versus isolated rapid eye movement sleep behavior disorder
Reddy, Neha V , Berns, Meaghan, Berns, Rachael, Olson, Hannah, Cui, Erija, Miglis, Mitchell G. , Boeve, Bradley F. , Ju, Yo‐El S. , Howell, Michael J. , Boeve, Brad , Howell, Michael J , Miglis, Mitchell G , Postuma, Ronald B.

SLEEP | August 19, 2024 | Volume: 47 | Issue: 11 | Pages: No page available

10.1093/sleep/zsae192 | PMID 39158284 Get It

Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity
Shaffer, Brian C. , Brown, Samantha , Chinapen, Stephanie , Mangold, Kathryn, Lahoud, Oscar , Schaffer, Wendy, Liu, Jennifer E. , Giralt, Sergio , Scordo, Michael , Papadopoulos, Esperanza B. , Landau, Heather , Friedman, Paul A. , Kosmidou, Ioanna , Giralt, Sergio , Papadopoulos, Esperanza , Landau, Heather , Perales, Miguel-Angel , Friedman, Paul A , Attia, Zachi I , Lahoud, Oscar B , López-Jiménez, Francisco , Devlin, Sean M. , Shah, Gunjan L. , Usmani, Saad Z. , Perales, Miguel‐Angel , Gersh, Bernard J. , Attia, Zachi I. , Noseworthy, Peter A.

Blood Advances | August 19, 2024 | Volume: 8 | Issue: 21 | Pages: 5603-5611

10.1182/bloodadvances.2024013636 | PMID 39158065 Get It

Abstract Artificial intelligence (AI)–enabled interpretation of electrocardiogram (ECG) images (AI-ECGs) can identify patterns predictive of future adverse cardiac events. We hypothesized that such an approach would provide prognostic information for the risk of cardiac complications and mortality in patients undergoing hematopoietic cell transplantation (HCT). We retrospectively subjected ECGs obtained before HCT to an externally trained, deep-learning model designed to predict the risk of atrial fibrillation (AF). Included were 1377 patients (849 autologous [auto] HCT and 528 allogeneic [allo] HCT recipients). The median follow-up was 2.9 years. The 3-year cumulative incidence of AF was 9% (95% confidence interval [CI], 7-12) in patients who underwent auto HCT and 13% (10%-16%) in patients who underwent allo HCT. In the entire cohort, pre-HCT AI-ECG estimate of AF risk correlated highly with the development of clinical AF (hazard ratio [HR], 7.37; 95% CI, 3.53-15.4; P < .001), inferior survival (HR, 2.4; 95% CI, 1.3-4.5; P = .004), and greater risk of nonrelapse mortality (NRM; HR, 95% CI, 3.36; 1.39-8.13; P = .007), without increased risk of relapse. Association with mortality was only noted in allo HCT recipients, where the risk of NRM was greater. The use of cyclophosphamide after transplantation resulted in greater 90-day incidence of AF (13% vs 5%; P = .01) compared to calcineurin inhibitor–based graft-versus-host disease prophylaxis, corresponding to temporal changes in AI-ECG AF prediction after HCT. In summary, AI-ECG can inform risk of posttransplant cardiac outcomes and survival in HCT patients and represents a novel strategy for personalized risk assessment.
A guide to large data sets for population‐based cancer research: Strengths, limitations, and pitfalls
Chan, Norine W. , Cheung, Dillon C., Fong, Zhi Ven , Chan, Norine W , Fong, Zhi Ven , Martin, Allison N. , Cheung, Dillon C

Cancer | August 19, 2024 | Volume: 130 | Issue: 22 | Pages: 3802-3814

10.1002/cncr.35535 | PMID 39158578 Get It

AbstractWith the proliferation of cancer research based on large databases, misalignment of research questions and data set capabilities is inevitable. Nationally maintained databases are appealing to cancer researchers because of the ease of access to large amounts of patient data available for analysis and risk estimation. Data sets that are commonly used in cancer research include the National Cancer Database, the SEER (Surveillance, Epidemiology, and End Results) program of the National Cancer Institute, the SEER–Medicare database, the American College of Surgeons National Surgical Quality Improvement Program, and the Healthcare Cost and Utilization Project databases, among others. Each data set has pros and cons with respect to variable availability and the ability to analyze cancer‐specific outcomes. It is critical for researchers to understand the strengths and limitations of each database. Changing variable definitions, the length of postoperative data collection, and the availability of patient‐reported outcomes or social determinants of health data are examples of factors that researchers must consider when selecting a data set for research purposes. For the current review, the authors summarized the advantages and disadvantages of various national data sets for cohort studies in cancer populations.
Poor prediction of stroke mimics using validated stroke mimic scales in a large academic telestroke network
Chhabra, Nikita , English, Stephen , Butterfield, Richard , Hanus, Abigail, Basharath, Rida, Miller, Monet, English, Stephen W , Hanus, Abigail E, Zhang, Nan , Demaerschalk, Bart M.

Journal of Telemedicine and Telecare | August 19, 2024 | Volume: 31 | Issue: 9 | Pages: 1278-1284

10.1177/1357633x241273762 | PMID 39158498 Get It

Introduction Telestroke enables timely and remote evaluation of patients with acute stroke syndromes. However, stroke mimics represent more than 30% of this population. Given the resources required for the management of suspected acute ischemic stroke, several scales have been developed to help identify stroke mimics. Our objective was to externally validate four mimic scales (Khan Score (KS), TeleStroke Mimic Score (TS), simplified FABS (sFABS), and FABS) in a large, academic telestroke network. Methods This is a retrospective, Institutional Review Board-exempt study of all patients who presented with suspected acute stroke syndromes and underwent video evaluation between 2019 and 2020 at a large academic telestroke network. Detailed chart review was conducted to extract both the variables needed to apply the mimic scales, the final diagnosis confirmed by final imaging, and discharge diagnosis (cerebral ischemic vs stroke mimic). Overall score performance was assessed by calculating the area under curve (AUC). Youden cutpoint was established for each scale and used to calculate sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and accuracy. Results A total of 1043 patients were included in the final analysis. Final diagnosis of cerebral ischemia was made in 63.5% of all patients, and stroke mimic was diagnosed in 381 patients (36.5%). To predict stroke mimic, TS had the highest AUC (68.3), sensitivity (99.2%), and NPV (77.3%); KS had the highest accuracy (67.5%); FABS had the highest specificity (55.1%), and PPV (72.5%). Conclusions While each scale offers unique strengths, none was able to identify stroke mimics effectively enough to confidently apply in clinical practice. There remains a need for significant clinical judgment to determine the likelihood of stroke mimic at presentation.
THE EFFECT OF CEMENTED FEMORAL COMPONENT DESIGN AND PROPHYLACTIC WIRE PLACEMENT AGAINST EARLY PERIPROSTHETIC FEMORAL FRACTURE IN PRIMARY TOTAL HIP ARTHROPLASTY: A BIOMECHANICAL STUDY
Zhao, Guangyue , Labott, Joshua R. , Restrepo, David J. , Hooke, Alexander W. , Zhao, Chunfeng , Perez, Sergio F. Guarin , Tsukamoto, Ichiro , Sierra, Rafael J.

Orthopaedic Proceedings | August 19, 2024 | Volume: 106-B | Issue: SUPP_16 | Pages: 45-45

10.1302/1358-992x.2024.16.045 Get It

Previous studies have highlighted differences in the risk of periprosthetic fracture between tapered slip (TS) and composite beam (CB) stems. This biomechanical study explored periprosthetic fractures around these stems and the effect of adding a 16-gauge calcar or diaphyseal wire to TS stems on their resistance to torque.A power analysis determined a sample size of 7 specimens per group, assuming a standard deviation of 14.8 Nm in peak torque, to provide 90% power to detect a difference of at least 30 Nm between groups. Twenty-one TS stems (eight alone, six with calcar wiring, seven with diaphyseal wiring placed 2 cm distal to the lesser trochanter) and seven CB stems were cemented into standard Sawbones. A servo-hydraulic test machine applied a 1000 N load with a 1-degree rotation per second until failure. The peak torque at failure was measured, and the fracture location recorded. Comparisons were performed using two-sample t-tests.CB stems exhibited a significantly higher peak torque at failure (205.3 Nm) than TS stems (159.5 Nm, p=0.020). Calcar-wire-TS (148.2 Nm, p=0.036) and diaphyseal-wire-TS (164.9 Nm, p=0.036) were both weaker than CB stems. Wired-TS stems showed no significant difference from non-wired-TS stems. Additionally, the study could not conclude that calcar wiring is stronger than diaphyseal wiring. All TS fractures occurred at the mid-stem, simulating a B-type fracture, while the addition of the diaphyseal wire shifted the fracture location more distally in four of seven stems (p=0.0699).This biomechanical study supports the clinical evidence that CB stems have stronger resistance to torque than TS stems and may explain lower risk of periprosthetic fracture. The addition of calcar or diaphyseal wires to TS stems resulted in no significant changes in peak torque to fracture. In patients at high risk of periprosthetic fracture, CB cemented stems should be considered.